Lundbeckfond Invest A/S 13D and 13G filings for Reneo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-26 4:10 pm Purchase | 2021-12-31 | 13G | Reneo Pharmaceuticals, Inc. RPHM | Lundbeckfond Invest A/S | 203,122 8.300% | 203,122 (New Position) | Filing |